title: New phthalocyanines for photodynamic virus inactivation in red blood cell concentrates.
abstract: Cationic phthalocyanines with either aluminum or silicon as the central metal were evaluated for their ability to inactivate viruses in red blood cell concentrates (RBCC) photodynamically. In addition, the virucidal potential of a substituted anionic phthalocyanine, aluminum dibenzodisulfophthalocyanine hydroxide (A1N2SB2POH) was evaluated and compared with that of the much studied anionic aluminum tetrasulfophthalocyanine hydroxide (A1PcS4OH). Based on the rate of inactivation of the lipid-enveloped vesicular stomatitis virus (VSV), the virucidal potential of these phthalocyanines was: HOSiPcOSi(CH3)2(CH2)3N+(CH3)3I- (Pc 5) = SiPc[OSi(CH3)2-(CH2)3N+(CH3)3I-]2 (Pc 6) > A1PcOSi(CH3)2(CH2)3N+(CH3)2(CH2)11CH3I- (Pc 21) = A1N2SB2POH = A1PcS4 > HOSiPc[OSi(CH3)2(CH2)3N+(CH3)2(CH2)11CH3I-]2 (Pc 14) > A1PcOSi(CH3)2(CH2)3N+(CH3)3I- (Pc 2). Phthalocyanine ligand 14 and Pc 21 are new phthalocyanines, made by quaternizing known amino analogues. Compared to VSV, the rate of inactivation of Sindbis virus (another model lipid-enveloped virus) was identical when treated in red blood cells (RBC) with Pc 5 and slightly higher when treated with Pc 6 and A1PcS4OH. Treatment of RBCC containing cell-free human immunodeficiency virus (HIV-1) with Pc 5 or A1PcS4OH required 15 min of irradiation to inactivate (> 5 log10 reduction) the virus. The extent of HIV-1 inactivation with A1N2SB2POH was 3.7 log10 after 60 min of red light exposure. The RBC integrity after photosensitization was measured by the ability of the cells to bind to plates coated with poly-L-lysine, (which reflects the retention of the RBC surface negative charges) and hemolysis of the cells over a 7 day storage period.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Lindsay F. Kimball Research Institute, New York Blood Center, NY 10021.
authors.forename: S
authors.initials: S
authors.lastname: Rywkin
authors.forename: E
authors.initials: E
authors.lastname: Ben-Hur
authors.forename: Z
authors.initials: Z
authors.lastname: Malik
authors.forename: A M
authors.initials: AM
authors.lastname: Prince
authors.forename: Y S
authors.initials: YS
authors.lastname: Li
authors.forename: M E
authors.initials: ME
authors.lastname: Kenney
authors.forename: N L
authors.initials: NL
authors.lastname: Oleinick
authors.forename: B
authors.initials: B
authors.lastname: Horowitz
mesh_terms: D017707:Erythrocyte Transfusion / Q000009:adverse effects; D004912:Erythrocytes / Q000187:drug effects / Q000382:microbiology* / Q000528:radiation effects; D006801:Humans; D066298:In Vitro Techniques; D007211:Indoles / Q000737:chemistry / Q000494:pharmacology*; D054833:Isoindoles; D010777:Photochemistry; D017319:Photosensitizing Agents / Q000494:pharmacology*; D012449:Safety; D014780:Viruses / Q000187:drug effects* / Q000528:radiation effects*
chemical_list: D007211:Indoles; D054833:Isoindoles; D017319:Photosensitizing Agents; C013647:phthalocyanine